“Efficacy and Safety of Ruxolitinib Cream by Anatomic Region in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, p. s453, https://doi.org/10.25251/skin.8.supp.453.